» Authors » K Tilleman

K Tilleman

Explore the profile of K Tilleman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 666
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Coleman E, Radix A, Bouman W, Brown G, de Vries A, Deutsch M, et al.
Int J Transgend Health . 2022 Oct; 23(Suppl 1):S1-S259. PMID: 36238954
Transgender healthcare is a rapidly evolving interdisciplinary field. In the last decade, there has been an unprecedented increase in the number and visibility of transgender and gender diverse (TGD) people...
2.
De Croo I, Colman R, De Sutter P, Stoop D, Tilleman K
Hum Reprod Open . 2022 Aug; 2022(3):hoac031. PMID: 35919767
Study Question: Is the cumulative live birth rate (CLBR) per oocyte collection cycle (OCC) comparable after cleavage-stage or blastocyst-stage transfer in combination with supernumerary blastocyst vitrification on Day 5 (D5)...
3.
De Witte L, Raman L, Baetens M, De Koker A, Callewaert N, Symoens S, et al.
Hum Reprod . 2022 May; 37(7):1678-1691. PMID: 35552408
Study Question: Is it possible to develop a comprehensive pipeline for all-in-one preimplantation genetic testing (PGT), also suitable for parents-only haplotyping and, for the first time, third-party reproduction? Summary Answer:...
4.
Lierman S, Bus A, Andries S, Trias E, Bols P, Tilleman K
Cryobiology . 2021 Jan; 100:164-172. PMID: 33485899
We aimed to assess the feasibility of passive slow freezing (PSF using Mr. Frosty container, Nalgene) as an alternative to controlled slow rate freezing (CSF using (Freezal™, Air liquide)) for...
5.
De Roo C, Lierman S, Tilleman K, De Sutter P
Hum Reprod Open . 2020 Nov; 2020(4):hoaa048. PMID: 33225076
Study Question: What is the role of the Hippo and PI3K/Akt pathway in follicles during ovarian tissue culture in tissue derived from oncological patients and transgender men? Summary Answer: Results...
6.
De Croo I, De Sutter P, Tilleman K
Hum Reprod Open . 2020 Sep; 2020(3):hoaa034. PMID: 32995561
Study Question: Is a stepwise change management approach an efficacious method to move from a Day 3 transfer policy to a Day 5 transfer policy for all patients in an...
7.
Blank C, DeCroo I, Weyers B, van Avermaet L, Tilleman K, van Rumste M, et al.
Eur J Obstet Gynecol Reprod Biol . 2020 Sep; 253:198-205. PMID: 32877773
Objective: The aim of this study was to evaluate the predictive value of the dynamic morphological development process between cleavage-stage and blastocyst-stage embryos. Study Design: A retrospective study was executed...
8.
Liu Y, Vlaeminck B, Tilleman K, Chouinard P, Gervais R, De Sutter P, et al.
J Assist Reprod Genet . 2020 Jan; 37(3):649-655. PMID: 31955340
Purpose: To examine the intra- and inter-individual variability in fatty acid composition of follicular fluid (FF) of 23 patients undergoing assisted reproductive treatment. Methods: The average coefficient of variation within...
9.
De Croo I, Colman R, De Sutter P, Tilleman K
Facts Views Vis Obgyn . 2019 Dec; 11(2):169-176. PMID: 31824637
Background: In an unselected patient population, what is the cumulative live birth rate per oocyte collection cycle in a blastocyst-stage transfer policy compared to a cleavage-stage transfer policy? Methods: A...
10.
De Roo C, Tilleman K, Vercruysse C, Declercq H, TSjoen G, Weyers S, et al.
J Assist Reprod Genet . 2019 Jul; 36(9):1837-1843. PMID: 31327130
Purpose: The importance of the surrounding ovarian stromal cells and extracellular matrix in the development and maturation of follicles has recently gained attention. An aberrant extracellular matrix has been described...